Influenza Vaccine Market Is it ready to combat seasonal outbreaks from 2025-2032?

The influenza virus circulates continue indefinitely, causing regional epidemics and outbreaks that have resulted in thousands of deaths. For instance, according to data from the Centers for Disease Control and Prevention (CDC), more than 13 million flu cases have been recorded in the 2019-20 timeframe. The changing nature of the virus necessitates an annual change in the vaccine strain to match the influenza virus strain around the world. During the forecasted period, the increasing prevalence of influenza epidemics and seasonal outbreaks is expected to boost product sales.

Influenza Vaccine Market size was valued at USD 7.91 Billion in 2023 and is poised to grow from USD 8.46 Billion in 2024 to USD 14.52 Billion by 2032, growing at a CAGR of 6.98% during the forecast period (2025-2032).

Get Your Free Sample Report Here @ https://www.skyquestt.com/sample-request/Influenza-vaccine-market

In the current market scenario, there are numerous licensed seasonal influenza vaccines recommended by the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and other governmental organizations to help fight the disease. Governments have focused on encouraging people to get vaccinated as soon as possible to provide the best possible protection during flu season. Furthermore, pharmaceutical companies are constantly confronted with new challenges in developing a suitable vaccine against a specific strain. As a result, rising demand for effective flu vaccines is expected to drive the Influenza Vaccine Market market.

Market Segmentation:

Global Influenza Vaccine Market is segmented on the basis of type, indication, route of administration, age group, distribution channel, and region.

By type, market is segmented into inactivated, and live attenuated.
By indication, market is segmented into quadrivalent, and trivalent.
By route od administration, injection, and nasal spray.
By age group, market is segmented into pediatric, and adult.
By distribution channel, market is segmented into hospital & pharmacies, government & institutional supply, and other.
By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Influenza Vaccine Market Key Players:

GSK plc (U.K.)
Pfizer Inc. (U.S.)
Vaxess Technologies Inc. (U.S.)
Merck & Co., Inc. (U.S.)
Viatris Inc. (U.S.)
OSIVAX (France)
AstraZeneca (U.K.)
SINOVAC (China)
CSL Limited (Australia)
Emergent BioSolutions Inc. (U.S.)
Emergex Vaccines (U.K.)
Sanofi (France)
BIKEN Co., Ltd. (Japan)
Abbott (U.S.)
Altimmune Inc. (U.S.)
Baxter International Inc. (U.S.)
BioDiem Ltd (Australia)
BiondVax Pharmaceuticals Ltd. (Israel)
F. Hoffmann-La Roche Ltd. (Switzerland)
FluGen Inc. (U.S.)
Mitsubishi Chemical Group Corp. (Japan)
Novavax Inc. (U.S.)
Otsuka Holdings Co. Ltd. (Japan)
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (China)
SK Chemicals Co., Ltd. (South Korea)

Influenza Vaccine Market Regional Insights:

In 2021, North America dominated the influenza vaccine market and is anticipated to maintain its dominance throughout the forecast period. Rapid product launches, combined with technologically advanced vaccine manufacturing systems across the region, are expected to drive market growth in the region. Furthermore, rising influenza prevalence and high vaccine sales are expected to fuel market growth in North America. Furthermore, rising government funding, the presence of strong key players, and sophisticated vaccination centres and hospitals will all contribute to the market's stellar growth.

Influenza Vaccine Key Market Trends:

The coronavirus pandemic had an unforeseen impact on routine immunization programmes and campaigns in both developing and developed countries. However, flu vaccination rates have increased significantly during the pandemic due to factors such as increased pressure from health experts/health departments, as well as the extension/expansion of various government programmes that provide free flu vaccination.

Furthermore, growing public awareness about the increased risk of getting infected with COVID-19 if the flu weakens the immune system is another factor contributing to flu vaccine uptake. For instance, the Centers for Disease Control and Prevention (CDC) reported that as of May, over 189.4 million flu vaccines for the 2020-2021 flu season had been distributed in the United States, compared to 174 million in the 2019-2020 season. In addition, according to the most recent study published in 2020, researchers in Brazil stated that a flu shot could reduce mortality rates by 20% when administrated prior to initiation of COVID-19 and by approximately 27% when administered after the onset of COVID-19. As a result, the above- mentioned factors are likely to drive demand over the forecast year.

What's more, it likewise covers the request and give of the promoting research concentrate in the assessed figure time frame. Explained investigation of the market players with their profile, deals examination and serious scene is given in the report. Besides, organization, joint effort and consolidations in the business are referenced for the accommodation of the investigation of the global Influenza Vaccine industry.

Related Reports:

https://ameblo.jp/insightdigits1/entry-12893129606.html
https://vinitsawant.hatenablog.com/entry/2025/04/08/220706?_gl=1*1g6mh4n*_gcl_au*NzA0MzAyMjA2LjE3NDI5MDgxOTA.

Objectives of the Study:

• To forecast the market size, in terms of value, for various segments with respect to five main regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
• To provide detailed information regarding the major factors influencing the growth of the Market (drivers, restraints, opportunities, and challenges)
• To strategically analyze the micro markets with respect to the individual growth trends, future prospects, and contribution to the total market
• To provide a detailed overview of the value chain and analyze market trends with the Porter's five forces analysis
• To analyze the opportunities in the market for various stakeholders by identifying the high-growth Segments
• To identify the key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for the market leaders
• To analyze competitive development such as joint ventures, mergers and acquisitions, new product launches and development, and research and development in the market

Looking ahead, the Influenza Vaccine Market is poised for continued growth, driven by evolving consumer preferences and ongoing innovations. The trend towards sustainability is expected to strengthen, with more consumers seeking products that align with their values. Additionally, the integration of advanced technologies and digital platforms will likely further enhance market accessibility and consumer engagement. The global Influenza Vaccine Market is a dynamic and evolving landscape, shaped by a confluence of trends and factors.

Browse Complete Report Influenza Vaccine Market for Better Understanding - https://www.skyquestt.com/report/Influenza-vaccine-market

Contact Us:

SkyQuest Technology
1 Apache Way, Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

This release was published on openPR.